XT
LLY icon

XTX Topco’s Eli Lilly LLY Stock Holding History

XTX Topco’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.39M Buy
6,991
+2,773
+66% +$2.83M 0.11% 175
2026
Q1 		$3.88M Buy
4,218
+3,266
+343% +$3.31M 0.07% 417
2025
Q4 		$1.02M Sell
952
-2,912
-75% -$2.78M 0.03% 1006
2025
Q3 		$2.95M Sell
3,864
-7,716
-67% -$5.74M 0.15% 114
2025
Q2 		$9.03M Buy
+11,580
New +$9M 0.37% 20
2024
Q3 		– Sell
-603
Closed -$546K – 2366
2024
Q2 		$546K Buy
+603
New +$482K 0.05% 615
2024
Q1 		– Sell
-1,266
Closed -$738K – 2115
2023
Q4 		$738K Sell
1,266
-4,965
-80% -$2.9M 0.16% 89
2023
Q3 		$3.35M Buy
+6,231
New +$3.21M 0.57% 1
2023
Q1 		– Sell
-2,471
Closed -$904K – 1486
2022
Q4 		$904K Buy
+2,471
New +$876K 0.19% 109
2022
Q2 		– Sell
-844
Closed -$242K – 980
2022
Q1 		$242K Buy
+844
New +$217K 0.11% 346

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco's LLY Position: Q2 2026 in Review

XTX Topco increased its Eli Lilly (LLY) stake by 66% in Q2 2026, buying an estimated $2.83M and bringing the position to 6,991 shares worth $8.39M. The position accounts for 0.11% of the portfolio, ranked #175.

XTX Topco first reported a position in LLY in Q1 2022 and has held it in 10 quarters since. The position peaked at $9.03M in Q2 2025. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • XTX Topco held 6,991 shares of Eli Lilly worth $8.39M as of Q2 2026.
  • XTX Topco bought 2,773 Eli Lilly shares in Q2 2026, an estimated $2.83M.
  • Eli Lilly made up 0.11% of XTX Topco's portfolio in Q2 2026, its #175 holding.
  • XTX Topco first reported a position in Eli Lilly in Q1 2022 and has held it in 10 quarters since.
  • XTX Topco's Eli Lilly position peaked at $9.03M in Q2 2025.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.